期刊的影响因子--文章列表

期刊文章列表
Yub Raj Neupane^1,2，Harish K.Handral³，Syed Abdullah Alkaff⁴，Wei Heng Chng^1,5，Gopalakrishnan Venkatesan^1,6，Chenyuan Huang^7,8,9，Choon Keong Lee¹，Jiong-Wei Wang^7,8,9,10，Gopu Sriram¹¹，Rhonnie Austria Dienzo¹²，Wen Feng Lu³，Yusuf Ali^12,13，Bertrand Czarny^4,12，Giorgia Pastorin^1,5,14（Department of Pharmacy，National University of Singapore；Department of Pharmaceutical Sciences and Experimental Therapeutics，the University of Iowa College of Pharmacy；Department of Mechanical Engineering，National University of Singapore；School of Materials Science and Engineering，Nanyang Technological University；Integrative Sciences and Engineering Programme，NUS Graduate School，National University of Singapore；Antimicrobial Resistance Interdisciplinary Research Group(AMR-IRG)，Singapore-MIT Alliance for Research and Technology；Department of Surgery，National University of Singapore；Cardiovascular Research Institute，National University Heart Centre；Nanomedicine Translational Research Programme，Centre for Nano Medicine，Yong Loo Lin School of Medicine，National University of Singapore；Department of Physiology，National University of Singapore；Faculty of Dentistry，National University of Singapore；Lee Kong Chian School of Medicine，Nanyang Technological University；Singapore Eye Research Institute(SERI)，Singapore General Hospital；NUSNNI-Nano Core，National University of Singapore）.Cell-derived nanovesicles from mesenchymal stem cells as extracellular vesicle-mimetics in wound healing[J].Acta Pharmaceutica Sinica B,2023,第5期 Mingyan Li¹，Yaling Wang^1,2，Lingzhi Zhang¹，Changxing Gao¹，Jing J.Li¹，Jiandong Jiang¹，Qing Zhu¹（State Key Laboratory of Bioactive Substance and Function of Natural Medicines，and Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study，Chinese Academy of Medical Sciences and Peking Union Medical College；College of Chinese Materia Medica and Yunnan Key Laboratory of Southern Medicinal Utilization，Yunnan University of Chinese Medicine）.Berberine improves central memory formation of CD8⁺ T cells：Implications for design of natural product-based vaccines[J].Acta Pharmaceutica Sinica B,2023,第5期 Endong Zhang¹，Philana Phan¹，Zongmin Zhao^1,2（Department of Pharmaceutical Sciences，College of Pharmacy，University of Illinois Chicago；Translational Oncology Program，University of Illinois Cancer Center）.Cellular nanovesicles for therapeutic immunomodulation：A perspective on engineering strategies and new advances[J].Acta Pharmaceutica Sinica B,2023,第5期 Rania Awad¹，Avi Avital²，Alejandro Sosnik¹（Laboratory of Pharmaceutical Nanomaterials Science，Department of Materials Science and Engineering，Technion-Israel Institute of Technology；Behavioral Neurobiology Laboratory，Department of Occupational Therapy，Faculty of Social Welfare and Health Sciences，University of Haifa）.Polymeric nanocarriers for nose-to-brain drug delivery in neurodegenerative diseases and neurodevelopmental disorders[J].Acta Pharmaceutica Sinica B,2023,第5期 Shameer M.Kondengadan，Shubham Bansal，Ce Yang，Dongning Liu，Zach Fultz，Binghe Wang（Department of Chemistry and Center for Diagnostics and Therapeutics，Georgia State University）.Click chemistry and drug delivery：A bird’s-eye view[J].Acta Pharmaceutica Sinica B,2023,第5期 Shuye Lin¹，Hanli Xu²，Lin Qin³，Mengdi Pang²，Ziyu Wang¹，Meng Gu¹，Lishu Zhang¹，Cong Zhao¹，Xuefeng Hao¹，Zhiyun Zhang¹，Weimin Ding³，Jianke Ren⁴，Jiaqiang Huang^1,2（Cancer Research Center，Beijing Chest Hospital，Capital Medical University，Beijing Tuberculosis and Thoracic Tumor Institute；College of Life Sciences & Bioengineering，Beijing Jiaotong University；Department of Endoscopic Diagnosis and Treatment，Beijing Chest Hospital，Capital Medical University，Beijing Tuberculosis and Thoracic Tumor Institute；CAS Key Laboratory of Computational Biology，Shanghai Institute of Nutrition and Health，University of Chinese Academy of Sciences，Chinese Academy of Sciences）.UHRF1/DNMT1—MZF1 axis-modulated intragenic site-specific CpGI methylation confers divergent expression and opposing functions of PRSS3 isoforms in lung cancer[J].Acta Pharmaceutica Sinica B,2023,第5期 Wen Zhu¹，Yang Wang¹，Liangyin Lv¹，Hui Wang¹，Wenqiang Shi¹，Zexin Liu¹，Mingzhe Zhou²，Jianwei Zhu¹，Huili Lu¹（Engineering Research Center of Cell and Therapeutic Antibody，Ministry of Education，School of Pharmacy，Shanghai Jiao Tong University；State Key Laboratory of Genetic Engineering，School of Life Science，Fudan University）.Universal chimeric Fcγ receptor T cells with appropriate affinity for IgG1 antibody exhibit optimal antitumor efficacy[J].Acta Pharmaceutica Sinica B,2023,第5期 Huiyang Wang，Yueyang Liu，Zhenkun Guo，Minghui Cui，Peng Pang，Jingyu Yang，Chunfu Wu（Department of Pharmacology，Shenyang Pharmaceutical University）.Enhancement of oligodendrocyte autophagy alleviates white matter injury and cognitive impairment induced by chronic cerebral hypoperfusion in rats[J].Acta Pharmaceutica Sinica B,2023,第5期 Rolande Meudom^1,2，Yanxian Zhang¹，Michael A.Vanden Berg³，Lei Zou³，Yi Wolf Zhang^1,2，Matthew J.Webber³，Danny Hung-Chieh Chou¹（Division of Endocrinology and Diabetes，Department of Pediatrics，School of Medicine，Stanford University；Department of Biochemistry，School of Medicine，University of Utah；Department of Chemical Engineering，University of Notre Dame）.Supramolecular approaches for insulin stabilization without prolonged duration of action[J].Acta Pharmaceutica Sinica B,2023,第5期 Jinmiao Lu，Hao Liu²，Qingtong Zhou^3,4，Ming-Wei Wang^3,4，Zhiping Li（Department of Pharmacy，Children’s Hospital of Fudan University，National Children’s Medical Center；School of Medicine，Ningbo University；Research Center for Deepsea Bioresources；Department of Pharmacology，School of Basic Medical Sciences，Fudan University）.A potentially serious adverse effect of GLP-1 receptor agonists[J].Acta Pharmaceutica Sinica B,2023,第5期 Sili Zheng¹，Zhiyong Li¹，Jie Song¹，Pin Wang¹，Jian Xu²，Wenjun Hu¹，Yi Shi³，Qi Qi¹，Zhuwei Miao¹，Yunfeng Guan¹，Chaoyu Miao¹（Department of Pharmacology，Second Military Medical University/Naval Medical University；Changhai Hospital，Second Military Medical University/Naval Medical University；Zhongshan Hospital，Fudan University）.Endothelial METRNL determines circulating METRNL level and maintains endothelial function against atherosclerosis[J].Acta Pharmaceutica Sinica B,2023,第4期 Zhihui Han¹，Xiang Gao²，Yuanjie Wang¹，Shuning Cheng¹，Xiaoyan Zhong³，Yong Xu⁴，Xiaozhong Zhou²，Zengli Zhang³，Zhuang Liu¹，Liang Cheng¹（Institute of Functional Nano & Soft Materials(FUNSOM)，Collaborative Innovation Center of Suzhou Nano Science and Technology，Soochow University；Department of Orthopedics，The Second Affiliated Hospital of Soochow University；Department of Environmental Health，School of Public Health，Soochow University；School of Materials and Energy，Guangdong University of Technology）.Ultrasmall iron-quercetin metal natural product nanocomplex with antioxidant and macrophage regulation in rheumatoid arthritis[J].Acta Pharmaceutica Sinica B,2023,第4期 Jiaxuan He¹，Qiao Duan^1,2，Chunyan Ran¹，Ting Fu^1,3，Yuan Liu¹，Weihong Tan^1,3,2（The Cancer Hospital of the University of Chinese Academy of Sciences(Zhejiang Cancer Hospital)，The Key Laboratory of Zhejiang Province for Aptamers and Theranostics，Hangzhou Institute of Medicine(HIM)，Chinese Academy of Sciences；Institute of Molecular Medicine(IMM)，Renji Hospital，Shanghai Jiao Tong University School of Medicine，and College of Chemistry and Chemical Engineering，Shanghai Jiao Tong University；Molecular Science and Biomedicine Laboratory(MBL)，State Key Laboratory of Chemo/Biosensing and Chemometrics，College of Chemistry and Chemical Engineering，College of Biology，Aptamer Engineering Center of Hunan Province，Hunan University）.Recent progress of aptamer-drug conjugates in cancer therapy[J].Acta Pharmaceutica Sinica B,2023,第4期 Libin Pan，Hang Yu，Jie Fu，Jiachun Hu，Hui Xu，Zhengwei Zhang，Mengmeng Bu，Xinyu Yang，Haojian Zhang，Jinyue Lu，Jiandong Jiang，Yan Wang（State Key Laboratory of Bioactive Substance and Function of Natural Medicines，Institute of Materia Medica，Chinese Academy of Medical Sciences/Peking Union Medical College）.Berberine ameliorates chronic kidney disease through inhibiting the production of gut-derived uremic toxins in the gut microbiota[J].Acta Pharmaceutica Sinica B,2023,第4期 Zhimei Xing^1,2，Han Gao^1,3，Dan Wang^1,2，Ye Shang^1,2，Tenukeguli Tuliebieke^1,2，Jibao Jiang⁴，Chunxiao Li^1,2，Hong Wang¹，Zhenguo Li⁵，Lifu Jia⁶，Yongsheng Wu⁵，Dandan Wang⁵，Wenzhi Yang^1,2，Yanxu Chang^1,2，Xiaoying Zhang^1,2，Liuwei Xu^1,2，Chao Jiang⁷，Luqi Huang⁷，Xiaoxuan Tian^1,2（State Key Laboratory of Component-Based Chinese Medicine，Tianjin University of Traditional Chinese Medicine；Haihe Laboratory of Modern Chinese Medicine；Jiangsu Key Laboratory for Biodiversity and Biotechnology，College of Life Sciences，Nanjing Normal University；School of Agriculture and Biology，Shanghai Jiao Tong University；Mudanjiang YouBo Pharmaceutical Co.Ltd.；Guizhou Ruihe Pharmaceutical Co.Ltd.；State Key Laboratory of Dao-di Herbs，National Resource Center for Chinese Materia Medica，China Academy of Chinese Medical Sciences）.A novel biological sources consistency evaluation method reveals high level of biodiversity within wild natural medicine：A case study of Amynthas earthworms as "Guang Dilong"[J].Acta Pharmaceutica Sinica B,2023,第4期 Xiaoxi Lv¹，Shanshan Liu²，Chang Liu，Yunxuan Li⁴，Tingting Zhang⁴，Jie Qi⁵，Ke Li⁴，Fang Hua¹，Bing Cui¹，Xiaowei Zhang¹，Yuxin Liu¹，Jiaojiao Yu¹，Jinmei Yu¹，Li Li¹，Xia Li⁵，Zhigang Yao⁶，Bo Huang⁷（State Key Laboratory of Bioactive Substance and Function of Natural Medicines，Institute of Materia Medica，Chinese Academy of Medical Sciences & Peking Union Medical College；National Clinical Research Center for Metabolic Diseases，Key Laboratory of Diabetes Immunology，Ministry of Education，And Department of Metabolism and Endocrinology，The Second Xiangya Hospital of Central South University；Drug Clinical Trial Institution，Children’s Hospital，Capital Institute of Pediatrics；Institute of Medicinal Biotechnology，Chinese Academy of Medical Sciences & Peking Union Medical College；Shandong University；Department of Respiratory Medicine，Beijing Friendship Hospital，Capital Medical University；Institute of Basic Medicine，Chinese Academy of Medical Sciences & Peking Union Medical College）.TRIB3 promotes pulmonary fibrosis through inhibiting SLUG degradation by physically interacting with MDM2[J].Acta Pharmaceutica Sinica B,2023,第4期 Yau-tuen Chan¹，Hor-yue Tan^1,2，Yuanjun Lu¹，Cheng Zhang¹，Chien-shan Cheng^1,3，Junyu Wu¹，Ning Wang¹，Yibin Feng¹（School of Chinese Medicine，the University of Hong Kong；Centre for Chinese Herbal Medicine Drug Development，School of Chinese Medicine，Hong Kong Baptist University；Department of Traditional Chinese Medicine，Shanghai Jiaotong University，School of Medicine Affiliated Ruijin Hospital）.Pancreatic melatonin enhances anti-tumor immunity in pancreatic adenocarcinoma through regulating tumor-associated neutrophils infiltration and NETosis[J].Acta Pharmaceutica Sinica B,2023,第4期 Yiwei Zhu，Lin Lei，Xinghui Wang，Linfang Chen，Wei Li，Jinxia Li，Chenchen Zhao，Xiliang Du，Yuxiang Song，Wenwen Gao，Guowen Liu，Xinwei Li（State Key Laboratory for Zoonotic Diseases，Key Laboratory of Zoonosis Research，Ministry of Education，College of Veterinary Medicine，Jilin University）.The E3 ubiquitin ligase NEDD4-1 protects against acetaminophen-induced liver injury by targeting VDAC1 for degradation[J].Acta Pharmaceutica Sinica B,2023,第4期 Bo Jin¹，Xuechao Pang¹，Qingce Zang¹，Man Ga¹，Jing Xu¹，Zhigang Luo¹，Ruiping Zhang¹，Jiangong Shi¹，Jiuming He^1,2，Zeper Abliz^1,3,4（State Key Laboratory of Bioactive Substance and Function of Natural Medicines，Institute of Materia Medica，Chinese Academy of Medical Sciences and Peking Union Medical College；NMPA Key Laboratory for Safety Research and Evaluation of Innovative Drug；Key Laboratory of Mass Spectrometry Imaging and Metabolomics(Minzu University of China)，National Ethnic Affairs Commission；Key Laboratory of Ethnomedicine of Ministry of Education，School of Pharmacy，Minzu University of China）.Spatiotemporally resolved metabolomics and isotope tracing reveal CNS drug targets[J].Acta Pharmaceutica Sinica B,2023,第4期 Kamila Butowska^1,2，Xuexiang Han¹，Ningqiang Gong¹，Rakan El-Mayta¹，Rebecca M.Haley¹，Lulu Xue¹，Wenqun Zhong³，Wei Guo³，Karin Wang⁴，Michael J.Mitchell^1,5,6,7,8（Department of Bioengineering，University of Pennsylvania；Intercollegiate Faculty of Biotechnology，University of Gda nsk & Medical University of Gda nsk；Department of Biology，University of Pennsylvania；Department of Bioengineering，Temple University；Abramson Cancer Center，Perelman School of Medicine，University of Pennsylvania；Institute for Immunology，Perelman School of Medicine，University of Pennsylvania；Cardiovascular Institute，Perelman School of Medicine，University of Pennsylvania；Institute for Regenerative Medicine，Perelman School of Medicine，University of Pennsylvania）.Doxorubicin-conjugated siRNA lipid nanoparticles for combination cancer therapy[J].Acta Pharmaceutica Sinica B,2023,第4期 Zi-Han Ye¹，Wei-Bang Yu¹，Mu-Yang Huang¹，Jun Chen²，Jin-Jian Lu^1,3,4,5（State Key Laboratory of Quality Research in Chinese Medicine，Institute of Chinese Medical Sciences，University of Macau；Zhongshan School of Medicine，Sun Yat-sen University；Department of Pharmaceutical Sciences，Faculty of Health Sciences，University of Macau；MoE Frontiers Science Center for Precision Oncology，University of Macau；Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research，University of Macau）.Building on the backbone of CD47-based therapy in cancer：Combination strategies, mechanisms, and future perspectives[J].Acta Pharmaceutica Sinica B,2023,第4期 Yixiang Xu¹，Chao Zhang¹，Kai Jiang²，Xinchun Yang³，Feng Chen²，Zhiyang Cheng²，Jinlong Zhao³，Jiaxing Cheng³，Xiaokang Li¹，Xin Chen¹，Luoyifan Zhou¹，Hao Duan¹，Yunyuan Huang⁴，Yaozu Xiang²，Jian Li^1,5,6,7（State Key Laboratory of Bioreactor Engineering，Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism，Frontiers Science Center for Materiobiology and Dynamic Chemistry，Shanghai Key Laboratory of New Drug Design，School of Pharmacy，East China University of Science and Technology；Shanghai East Hospital，School of Life Sciences and Technology，Tongji University；East China University of Science and Technology-Tengbai Pharmaceutical Innovative Drugs Joint Research Institute，Zhuhai Tengbai Pharmaceutical Co.，Ltd.；Hubei Key Laboratory of Genetic Regulation and Integrative Biology，School of Life Sciences，Central China Normal University；Yunnan Key Laboratory of Screening and Research on Anti-pathogenic Plant Resources from West Yunnan，College of Pharmacy，Dali University；Clinical Medicine Scientific and Technical Innovation Center，Shanghai Tenth People's Hospital，Tongji University School of Medicine；Key Laboratory of Tropical Biological Resources of Ministry of Education，College of Pharmacy，Hainan University）.Structural repurposing of SGLT2 inhibitor empagliflozin for strengthening anti-heart failure activity with lower glycosuria[J].Acta Pharmaceutica Sinica B,2023,第4期 Jingjing Gao^1,2，Ziting Xia¹，Dilrasbonu Vohidova¹，John Joseph^1,2，James N.Luo^2,4，Nitin Joshi^1,2（Center for Nanomedicine，Department of Anesthesiology，Perioperative and Pain Medicine，Brigham and Women's Hospital；Harvard Medical School；Center for Nanomedicine，Department of Anesthesiology，Perioperative and Pain Medicine，Brigham and Women’s Hospital；Department of Surgery，Brigham and Women's Hospital）.Progress in non-viral localized delivery of siRNA therapeutics for pulmonary diseases[J].Acta Pharmaceutica Sinica B,2023,第4期 Yongxi Liang¹，Delin Min¹，Hulin Fan¹，Kunlin Liu¹，Juchuanli Tu²，Xueyan He²，Bingjie Liu²，Lu Zhou¹，Suling Liu²，Xun Sun^1,3（School of Pharmacy，Fudan University；Fudan University Shanghai Cancer Center & Institutes of Biomedical Sciences，State Key Laboratory of Genetic Engineering，Fudan University；The Institutes of Integrative Medicine of Fudan University）.Discovery of a first-in-class ANXA3 degrader for the treatment of triple-negative breast cancer[J].Acta Pharmaceutica Sinica B,2023,第4期 Yuyu Liu，Xinnan Li，Songyang Sui，Jingshu Tang，Dawei Chen，Yuying Kang，Kebo Xie，Jimei Liu，Jiaqi Lan，Lei Wu，Ridao Chen，Ying Peng，Jungui Dai（State Key Laboratory of Bioactive Substance and Function of Natural Medicines，CAMS Key Laboratory of Enzyme and Biocatalysis of Natural Drugs，and NHC Key Laboratory of Biosynthesis of Natural Products，Institute of Materia Medica，Chinese Academy of Medical Sciences and Peking Union Medical College）.Structural diversification of bioactive bibenzyls through modular co-culture leading to the discovery of a novel neuroprotective agent[J].Acta Pharmaceutica Sinica B,2023,第4期 Mingming Zheng¹，Wenxin Zhang¹，Xi Chen¹，Hongjie Guo¹，Honghai Wu¹，Yanjun Xu²，Qiaojun He^1,3,4，Ling Ding¹，Bo Yang^1,3（Zhejiang Province Key Laboratory of Anti-Cancer Drug Research，Institute of Pharmacology and Toxicology，College of Pharmaceutical Sciences，Zhejiang University；Department of Medical Thoracic Oncology，the Cancer Hospital of University of Chinese Academy of Sciences(Zhejiang Cancer Hospital)，Chinese Academy of Sciences；The Innovation Institute for Artificial Intelligence in Medicine，Zhejiang University；Cancer Center of Zhejiang University）.The impact of lipids on the cancer—immunity cycle and strategies for modulating lipid metabolism to improve cancer immunotherapy[J].Acta Pharmaceutica Sinica B,2023,第4期首页上一页 6 7 8 9 10 下一页尾页共有12页，转到页

期刊文章列表